Business Context and Reporting Period
This Form 8-K was filed by NanoVibronix, Inc. on December 4, 2018. The report addresses a material event regarding the company's compliance with NASDAQ listing requirements. Note: The metadata provided lists "Envue Medical, Inc.", but the filing text explicitly identifies the registrant as "NanoVibronix, Inc."
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses solely on the company's failure to meet the minimum stockholders' equity requirement of $2,500,000 under NASDAQ Listing Rule 5550(b)(1).
Material Changes and Events
- Non-Compliance Notice: On September 14, 2018, NASDAQ notified the company of non-compliance due to insufficient stockholders' equity.
- Compliance Plan: The company submitted a plan to regain compliance on October 26, 2018.
- Extension Granted: On December 4, 2018, NASDAQ granted a 180-day extension until March 13, 2019, to demonstrate compliance.
- Conditions: The extension is subject to the company providing interim progress reports to the Listing Qualifications Department.
Outlook, Risks, and Contingencies
Delisting Risk: If the company cannot demonstrate compliance by March 13, 2019, NASDAQ will provide written notification that the common stock could be delisted.
Appeal Process: In the event of a delisting determination, the company may appeal to a NASDAQ Hearings Panel.
Management Commentary: The filing explicitly states there can be no assurance that the company will be able to regain compliance with NASDAQ listing rules or maintain its listing on the NASDAQ Capital Market.
Investor Verification Checklist
- Verify the current stockholders' equity balance to assess progress toward the $2,500,000 threshold.
- Monitor interim progress reports submitted to NASDAQ between December 2018 and March 2019.
- Confirm the company's status on the NASDAQ Capital Market leading up to the March 13, 2019 deadline.
- Review any subsequent filings for updates on the compliance plan or potential delisting notices.